(Q80347916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye WorkShop (2007) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

153-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

Challenges and pitfalls in clinical trials of treatments for dry eye.

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Reporting financial conflicts of interest and relationships between investigators and research sponsors.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Conflicts of interest in clinical research: opprobrium or obsession?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Academic relationships with industry: a new model for biomedical research.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Toward the operational identification of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Methodologies for the study of ocular surface disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Preservation of corneal integrity by the mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced dry eye

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Androgen regulation of lipogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Artificial tear composition and promotion of recovery of the damaged corneal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Tear Osmolarity and Ocular Surface Disease in Keratoconjunctivitis Sicca

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Controlled study of the use of autologous serum in dry eye patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Treatment of dry eye by autologous serum application in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Stimulation of tear secretion and treatment of dry-eye disease with 3-isobutyl-1-methylxanthine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Tear lipocalin: structure, function and molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Gefarnate stimulates secretion of mucin-like glycoproteins by corneal epithelium in vitro and protects corneal epithelium from desiccation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Dry eye treatment with eye drops that stimulate mucin production.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Characterization of human ocular mucin secretion mediated by 15(S)-HETE.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The eicosanoid, 15-(S)-HETE, stimulates secretion of mucin-like glycoprotein by the corneal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Punctal occlusion in tear deficiency syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Spectacle side panels and moist inserts for the treatment of dry-eye patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The effect of wearing spectacles on the humidity of the eye

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Combination of a side shield with an ocular moisture chamber

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Treatment of corneal xerophthalmia with topical retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Symptoms of ocular irritation in patients diagnosed with dry eye

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Relation between signs and symptoms of dry eye in the elderly. A population-based perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Test and symptoms in keratoconjunctivitis sicca and their correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Patient-reported symptoms in dry dye disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Assessing the severity of keratitis sicca with videokeratoscopic indices

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Lissamine green. Vital staining of cornea and conjunctiva.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Vital staining of cornea and conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Corneal staining patterns in normal non-contact lens wearers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Corneal staining characteristics after sequential instillations of fluorescein

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

Corneal Staining after Sequential Instillations of Fluorescein Over 30 Days

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970084-8

7 January 2021

10.1016/S1542-0124(12)70084-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17508119%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference